STTK Shattuck Labs: Rasio rega marang prakiraan pendapatan
Shattuck Labs, Inc. (STTK) develops breakthrough protein-based therapies to combat tumors via dual immune activation. The forward P/S ratio on GURU.Markets captures valuation dynamics, where the 456.70 mark reflects the current state. The model relies on external CRO contractors for testing, minimizing manufacturing plant expenditures. Development risks are mitigated by a liquidity reserve and a broad spectrum of researched cancer types.
Rincian analitis perusahaan shattucklabs.com (STTK)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Shattuck Labs, Inc.|STTK - Rasio silihan jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Shattuck Labs|STTK - Tanggungan utang kumulatif perusahaan|Utang marang nilai buku STTK|STTK - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Shattuck Labs|Likuiditas cepet shattucklabs.com
- rincian asil keuangan lan kelipatan valuasi:
STTK - Bathi resik|Bathi mangsa ngarep Shattuck Labs, Inc.|STTK - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep Shattuck Labs|STTK - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA STTK|STTK - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Shattuck Labs|STTK - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan shattucklabs.com|STTK - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Shattuck Labs, Inc.
- statistik dodolan lan pendapatan perusahaan:
Analisis umum perusahaan:Shattuck Therapeutics (STTK)
Forward P/S measures an asset's market value relative to expected revenue, determining whether a business is overvalued or undervalued. The price-to-sales forward multiple reflects the valuation's sensitivity to license fee forecasts for Shattuck Labs, Inc. (STTK), where an increase in the indicator signals that the market is pricing in the success of clinical trials for solid tumor and lymphoma therapies.
Pesaing Shattuck Labs, Inc.
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABVX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake ADMA Corp ADMA|PTGX: Multiplikator Forward P/S|immunovant.com - Rega forward marang dodolan|KNSA (Kiniksa) - Multiplikator Forward P/S|Multiplikator Forward P/S Grifols SA|Multiplikator forward rega marang pendapatan ADPT (Adaptive Biotechnologies Corp)|Rasio rega marang pendapatan sing dikarepake CLDX|Aurinia Pharmaceuticals - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake BCRX (biocryst.com)|VERA: Multiplikator forward rega marang pendapatan|DNTH - Multiplikator Forward P/S|PHVS: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan AbCellera Corp|Rasio rega marang prakiraan pendapatan Tourmaline Bio, Inc.|Multiplikator Forward P/S precigen.com|Multiplikator forward rega marang pendapatan PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Upstream Bio Corp UPB|Zenas Corp - Rasio rega marang prakiraan pendapatan|Immunome, Inc. - Multiplikator Forward P/S|GOSS - Multiplikator Forward P/S|KALV: Multiplikator Forward P/S|SEPN (Septerna, Inc.) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Pieris Pharmaceuticals Inc|Savara Pharma (SVRA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan RIGL (Rigel Pharmaceuticals)|ANAB (anaptysbio.com) - Rega forward marang dodolan|Multiplikator Forward P/S ATXS (Astria Therapeutics, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc (ENGN)|RAPT - Rasio rega marang prakiraan pendapatan|JBIO (Aerovate Therapeutics Inc) - Kapitalisasi marang prakiraan pendapatan|ACRS: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan kyvernatx.com|Multiplikator forward rega marang pendapatan TLSA|Cabaletta Bio Inc. (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Ventyx Bio (VTYX)|Rasio kapitalisasi marang dodolan sing dikarepake Theratechnologies, Inc|Avalo Therapeutics, Inc - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ELDN (eledon.com)|AGEN: Multiplikator forward rega marang pendapatan|Climb Bio Inc. - Rasio rega marang pendapatan sing dikarepake|Zura Bio Limited (ZURA) - Rasio rega marang prakiraan pendapatan|aTyr Pharmaceuticals (ATYR) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Adagene Inc|Ikena Oncology, Inc. - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S EQ|CNTB (connectbiopharm.com) - Rega forward marang dodolan|Multiplikator Forward P/S IMUX (Immunic)|Multiplikator Forward P/S Atara Biotherapeutics, Inc. ATRA|IFRX - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan XFOR (x4pharma.com)|adicetbio.com (ACET) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Celularity|INMB (INmune Bio Corp) - Multiplikator Forward P/S|Multiplikator Forward P/S Barinthus Biotherapeutics Corp|Multiplikator forward rega marang pendapatan KZR (Kezar Life Sciences)|SABS (sabbiotherapeutics.com) - Rega forward marang dodolan|Multiplikator Forward P/S AKTX (Akari Therapeutics Plc)|Rasio kapitalisasi marang dodolan sing dikarepake Enlivex Therapeutics Ltd (ENLV)|QTTB - Rasio rega marang prakiraan pendapatan|GeoVax Corp (GOVX) - Multiplikator forward rega marang pendapatan|Edesa Biotech, Inc. (EDSA) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan ibioinc.com|Multiplikator forward rega marang pendapatan CARM|Multiplikator Forward P/S XTL Biopharmaceuticals Ltd|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ADTX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake GRI Bio Inc GRI|XRTX: Multiplikator Forward P/S|Vyome Therapeutics - Rega forward marang dodolan|REVB (Revelation Biosciences) - Multiplikator Forward P/S|Multiplikator Forward P/S indaptusrx.com|Multiplikator forward rega marang pendapatan SCNI (Scinai Immunotherapeutics Ltd.)|Rasio rega marang pendapatan sing dikarepake CALI|Affimed N.V. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ALLK (Allakos Inc)|HOOK: Multiplikator forward rega marang pendapatan|IGMS - Multiplikator Forward P/S|ITOS: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Ocean Biomedical Inc|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator Forward P/S Third Harmonic Bio Inc
